Dimitri Budinger

Dimitri Budinger

Auto-generated profile, based on publicly available information

Dimitri Budinger

Luxembourg Centre for Systems Biomedicine, University of Luxembourg , Belvaux L-4367

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
DBDimitri Budinger
Dimitri Budinger
PPPau Puigdevall
Pau Puigdevall
GHGeorge T. Hall
George T. Hall
CRCharlotte Roth
Charlotte Roth
TXTheodoros Xenakis
Theodoros Xenakis
SBSerena Barral
Serena Barral
The dopaminergic system has key roles in human physiology and is implicated in a broad range of neurological and neuropsychiatric conditions that are increasingly investigated using induced pluripotent stem cell-derived midbrain models. To determine similarities of such models to human systems, here we undertake single-cell and spatial profiling of first and second trimester fetal midbrain and compare it to in vitro midbrain models. Histological examination reveals that, by the second trimester, fetal midbrain tissue exhibits structural complexity comparable to that of adults. At the molecular level, single-cell profiling uncovers differences in cellular composition across models, with brain organoids most closely resembling late first trimester tissue — an observation supported by meta-integration of existing midbrain datasets. By reconstructing developmental trajectories of neuronal and astrocytic lineages, we map gene expression dynamics associated with maturation. Importantly, integration of spatial transcriptomics provides critical context for aligning organoid models, revealing that their spatial organization and intercellular signaling resemble the architecture and microenvironment of the second trimester midbrain. Ultimately, we leverage our findings to study Dopamine Transporter Deficiency Syndrome progression in patient-derived midbrain organoids, validating their relevance. Understanding the extent of human tissue recapitulation in midbrain laboratory models is essential to justify their use as biological proxies.

6 May 2026 in Brain
Verified
Journal Article
Open access
SMSrivathsa Subramanya Magadi
Srivathsa Subramanya Magadi
MJMaria Jonson
Maria Jonson
PLPablo B Lucena
Pablo B Lucena
MCMichele F Caliandro
Michele F Caliandro
BABeatriz Almeida
Beatriz Almeida
WJWalker Jackson
Walker Jackson
Neuroinflammation, particularly that involving reactive microglia, the brain’s resident immune cells, is implicated in the pathogenesis of major neurodegenerative diseases (NDs). Multiple studies have reported changes in ribosomal protein (RP) expression during neurodegeneration, but the significance of these changes remains unclear. Ribosomes are evolutionarily conserved protein-synthesizing machines; although commonly viewed as invariant, accumulating evidence suggests functional ribosome specialization through variation in their protein composition. Among RPs, S24, encoded by RPS24 in humans and Rps24 in mice, is unique as its transcripts undergo alternative splicing to produce protein variants with different C-terminal sequences that are differentially expressed across tissues and cell types. Understanding heterogeneous RP expression patterns across brain regions and cell types could reveal mechanisms underlying selective vulnerability in NDs and provide new biomarkers for neuroinflammatory responses. To characterize RP expression patterns across brain regions in neurons, astrocytes and microglia, we analysed cell type-specific translating mRNAs from mice. To investigate Rps24 isoform-specific expression, we performed cell type-resolved transcript analysis and developed antibodies specific for the S24-PKE protein variant encoded by mRNA isoform Rps24c. We examined Rps24c/S24-PKE expression in brains from mouse models of ageing and neurodegeneration, as well as in human post-mortem tissue from patients with Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). This work revealed distinct RP expression patterns across brain regions and between neurons, astrocytes and microglia, including neuron-enriched RPs Rpl13a and Rps10. Analysis of RP paralogues revealed complex expression relationships with their canonical counterparts, suggesting regulated mechanisms for generating heterogeneous ribosomes. Across brain regions and cell types, Rplp0 and Rpl13a, commonly used normalization references, showed heterogeneous expression, raising important methodological considerations for gene expression studies. Rps24 isoforms exhibited striking cell type-specific expression patterns. Rps24c was predominantly expressed in microglia and was increased by neuroinflammation caused by ageing, neurodegeneration or inflammatory chemicals. Using S24-PKE-specific antibodies, we verified increased expression of this protein variant in brains with AD, PD and HD, and in relevant mouse models. These findings establish heterogeneous RP expression as a feature of brain cell types which may enable cell type-specific translation regulation via specialized ribosomes. This work also identifies Rps24c/S24-PKE as a potential novel marker for neuroinflammation and neurodegeneration and provides new tools for monitoring these responses.